Renaissance Technologies LLC Has $999,000 Stake in Trupanion, Inc. $TRUP

Key Points

• Renaissance Technologies increased its Trupanion stake by 550% in the first quarter, purchasing 33,000 additional shares and ending with 39,000 shares valued at approximately $999,000.
• Analysts maintain a generally positive outlook, with Trupanion receiving a consensus “Moderate Buy” rating and an average price target of $41.60.
• Trupanion reported quarterly EPS of $0.16, beating estimates of $0.11, while revenue rose 11.1% year over year to $392.93 million.

Renaissance Technologies LLC increased its stake in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 550.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 39,000 shares of the financial services provider's stock after purchasing an additional 33,000 shares during the quarter. Renaissance Technologies LLC owned about 0.09% of Trupanion worth $999,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Thrivent Financial for Lutherans lifted its holdings in Trupanion by 1.1% during the 2nd quarter. Thrivent Financial for Lutherans now owns 24,853 shares of the financial services provider's stock worth $1,376,000 after buying an additional 282 shares in the last quarter. EP Wealth Advisors LLC increased its stake in shares of Trupanion by 2.9% in the 2nd quarter. EP Wealth Advisors LLC now owns 10,310 shares of the financial services provider's stock valued at $571,000 after buying an additional 292 shares during the period. Illinois Municipal Retirement Fund grew its position in shares of Trupanion by 2.3% during the 1st quarter. Illinois Municipal Retirement Fund now owns 17,819 shares of the financial services provider's stock worth $456,000 after buying an additional 406 shares during the period. Price T Rowe Associates Inc. MD grew its holdings in Trupanion by 2.2% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 33,657 shares of the financial services provider's stock worth $1,258,000 after acquiring an additional 725 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Trupanion by 3.8% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,340 shares of the financial services provider's stock worth $1,126,000 after purchasing an additional 737 shares during the period.

Wall Street Analyst Weigh In

TRUP has been the topic of several analyst reports. Atlantic Securities set a $42.00 target price on Trupanion in a research note on Wednesday, July 15th. Stifel Nicolaus set a $28.00 price target on shares of Trupanion in a research report on Friday, June 26th. Zacks Research raised shares of Trupanion from a "hold" rating to a "strong-buy" rating in a research note on Friday, July 24th. Finally, Weiss Ratings raised shares of Trupanion from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Wednesday. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, Trupanion has a consensus rating of "Moderate Buy" and an average target price of $41.60.

Trupanion Stock Performance

TRUP stock opened at $30.60 on Friday. The business's 50-day moving average price is $25.56 and its two-hundred day moving average price is $26.11. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24. The firm has a market cap of $1.34 billion, a PE ratio of 57.74, a P/E/G ratio of 2.23 and a beta of 1.39. Trupanion, Inc. has a 1-year low of $21.16 and a 1-year high of $49.90.

Trupanion (NASDAQ:TRUP - Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The company had revenue of $392.93 million during the quarter, compared to the consensus estimate of $389.72 million. During the same period in the prior year, the company earned $0.22 earnings per share. The company's revenue for the quarter was up 11.1% compared to the same quarter last year. As a group, research analysts forecast that Trupanion, Inc. will post 0.59 earnings per share for the current year.

Insider Activity at Trupanion

In other Trupanion news, CFO Fawwad Qureshi sold 6,177 shares of Trupanion stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $22.18, for a total value of $137,005.86. Following the transaction, the chief financial officer owned 2,081 shares of the company's stock, valued at approximately $46,156.58. The trade was a 74.80% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Steve Weinrauch sold 6,674 shares of Trupanion stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $22.00, for a total transaction of $146,828.00. Following the completion of the transaction, the executive vice president directly owned 78,062 shares in the company, valued at approximately $1,717,364. The trade was a 7.88% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 18,785 shares of company stock valued at $422,862. Corporate insiders own 5.58% of the company's stock.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company's core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.

Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source